ArticleFrontiers in oncology2022

Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors.

Richard Benjamin Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.